Pharmacore Biotech Co., Ltd.
Records under this name other than patents Pharmacore Biotech Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 2 of 2 · Back to Pharmacore Biotech Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,934,315 | Process for preparing bortezomib, intermediates, and crystalline forms thereof Lapsed on the fee record Ended Mar 2, 2025 · USPTO record | Lapsed on the fee record | Ended Mar 2, 2025 | USPTO record |
| US 10,479,811 | Process for preparing cyclophosphamide, intermediates, and monohydrate thereof Lapsed on the fee record Ended Nov 19, 2023 · USPTO record | Lapsed on the fee record | Ended Nov 19, 2023 | USPTO record |